中国腹腔镜胃肠外科研究组CLASS-01研究进展

Progress of CLASS-O1 trial of Chinese laparoscopic gastro- intestinal surgery study group

我国胃肠微创外科发展日新月异，中国腹腔镜胃肠外科研究组（CLASS）作为成立最早、多中心合作最紧密的外科临床研究协作组织，在中华医学会、中国医师协会、中国抗癌协会的共同指导和帮助下，临床研究能力与微创技术水平持续提升。随着2012年CLASS-01局部进展期远端胃癌前瞻性、随机、对照临床研究的启动与2016年胃癌腹腔镜手术安全性结果的发布，国际学术界将越来越多的关注目光投向了中国。笔者回顾CLASS成立7年来的发展历程，展望愿景，共勉开创新篇。

The development of gastrointestinal minimally invasive surgery in China is changing during the past decade. The Chinese laparoscopic gastrointestinal surgery study （CLASS） group as the earliest and most closely cooperated organization for surgical clinical researches, under the support of Chinese Medical Association, Chinese Anti cancer Association and Chinese Medical Doctor Association, the clinical research capacity and minimally invasive technology of the CLASS group continue to be developed. With the launch of the prospective, randomized, controlled CLASS-01 trial for the treatment of locally advanced gastric cancer in 2012 and the publication of safety results of laparoscopic surgery for gastric cancer in 2016, the international academic community is increasingly focusing its attention on China.This article attempts to review the history and development of the CLASS group in the past 7 years, aiming to prospect the future and attempt to create trends.